TY  - RPRT
TI  - A Seamless Phase I/II Platform Design with a Time-To-Event Efficacy Endpoint for Potential COVID-19 Therapies
AU  - Thomas Jaki
AU  - Helen Barnett
AU  - Andrew Titman
AU  - Pavel Mozgunov
PY  - 2020
UR  - https://arxiv.org/abs/2010.06518
ID  - 2010.06518
ER  -